Knowles, Emma EM Meikle, Peter J Huynh, Kevin Göring, Harald HH Olvera, Rene L Mathias, Samuel R Duggirala, Ravi Almasy, Laura Blangero, John Curran, Joanne E and Glahn, David C 2017. Serum phosphatidylinositol as a biomarker for bipolar disorder liability. Bipolar Disorders, Vol. 19, Issue. 2, p. 107.
Zhang, Yue Peti-Peterdi, János Brandes, Anna U. Riquier-Brison, Anne Carlson, Noel G. Müller, Christa E. Ecelbarger, Carolyn M. and Kishore, Bellamkonda K. 2017. Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice. Purinergic Signalling, Vol. 13, Issue. 2, p. 239.
Alda, Martin and Manchia, Mirko 2017. Personalized management of bipolar disorder. Neuroscience Letters,
Kellner, Charles H. Li, Erin H. Farber, Kate G. Geduldig, Emma T. and Ahle, Gabriella M. 2016. Electroconvulsive Therapy (ECT) and Suicide Prevention. Current Treatment Options in Psychiatry, Vol. 3, Issue. 1, p. 73.
Zimmerman, Mark 2016. Improving the Recognition of Borderline Personality Disorder in a Bipolar World. Journal of Personality Disorders, Vol. 30, Issue. 3, p. 320.
Ketter, Terence A. Amchin, Jess Frye, Mark A. and Gross, Nicholas 2016. Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study. Journal of Affective Disorders, Vol. 197, p. 51.
Tharp, Jordan A. Johnson, Sheri L. Sinclair, Sungchoon and Kumar, Sant 2016. Goals in bipolar I disorder: Big dreams predict more mania. Motivation and Emotion, Vol. 40, Issue. 2, p. 290.
Tsai, Chia-Jui Cheng, Chin Chou, Po-Han Lin, Ching-Heng McInnis, Melvin G. Chang, Chia-Li and Lan, Tsuo-Hung 2016. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan. Journal of Affective Disorders, Vol. 196, p. 71.
Inder, Maree L Crowe, Marie T Luty, Suzanne E Carter, Janet D Moor, Stephanie Frampton, Christopher M and Joyce, Peter R 2016. Prospective rates of suicide attempts and nonsuicidal self-injury by young people with bipolar disorder participating in a psychotherapy study. Australian & New Zealand Journal of Psychiatry, Vol. 50, Issue. 2, p. 167.
Balasubramanian, Diana Deng, Alicia X. Doudney, Kit Hampton, Mark B. and Kennedy, Martin A. 2015. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line. Neuropharmacology, Vol. 99, p. 79.
Olié, E. Seyller, M. Beziat, S. Loftus, J. Bellivier, F. Bougerol, T. Belzeaux, R. Azorin, J. M. Gard, S. Kahn, J. P. Passerieux, C. Leboyer, M. Etain, B. Henry, C. and Courtet, P. 2015. Clinical and neuropsychological characteristics of euthymic bipolar patients having a history of severe suicide attempt. Acta Psychiatrica Scandinavica, Vol. 131, Issue. 2, p. 129.
Van Meter, Anna R. and Youngstrom, Eric A. 2015. A tale of two diatheses: Temperament, BIS, and BAS as risk factors for mood disorder. Journal of Affective Disorders, Vol. 180, p. 170.
Dell’Osso, Bernardo Holtzman, Jessica N. Goffin, Kathryn C. Portillo, Natalie Hooshmand, Farnaz Miller, Shefali Dore, Jennifer Wang, Po W. Hill, Shelley J. and Ketter, Terence A. 2015. American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways. Journal of Affective Disorders, Vol. 188, p. 257.
Costa, Lucas da Silva Alencar, Átila Pereira Neto, Pedro Januário Nascimento Santos, Maria do Socorro Vieira dos da Silva, Cláudio Gleidiston Lima Pinheiro, Sally de França Lacerda Teixeira Silveira, Regiane Bianco, Bianca Alves Vieira Pinheiro Júnior, Roberto Flávio Fontenelle de Lima, Marcos Antonio Pereira Reis, Alberto Olavo Advincula and Neto, Modesto Leite Rolim 2015. Risk factors for suicide in bipolar disorder: A systematic review. Journal of Affective Disorders, Vol. 170, p. 237.
Clements, Caroline Jones, Steve Morriss, Richard Peters, Sarah Cooper, Jayne While, David and Kapur, Navneet 2015. Self-harm in bipolar disorder: Findings from a prospective clinical database. Journal of Affective Disorders, Vol. 173, p. 113.
Zimmerman, Mark 2015. Borderline Personality Disorder. The Journal of Nervous and Mental Disease, Vol. 203, Issue. 1, p. 8.
Kim, Mi-Young Ha, Su-Jung and Jun, Seong-Sook 2015. Factors related to Suicidal Ideation in Patients with Chronic Schizophrenia, Depressive Disorder, or Bipolar Disorder. Journal of Korean Academy of Psychiatric and Mental Health Nursing, Vol. 24, Issue. 4, p. 217.
Rygula, Rafal Golebiowska, Joanna Kregiel, Jakub Holuj, Malgorzata and Popik, Piotr 2015. Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats. Psychopharmacology, Vol. 232, Issue. 12, p. 2149.
Kishore, B. K. Carlson, N. G. Ecelbarger, C. M. Kohan, D. E. Müller, C. E. Nelson, R. D. Peti-Peterdi, J. and Zhang, Y. 2015. Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. Acta Physiologica, Vol. 214, Issue. 2, p. 176.
Sandberg, Johan V. Jakobsson, Joel Pålsson, Erik Landén, Mikael and Mathé, Aleksander A. 2014. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts. European Neuropsychopharmacology, Vol. 24, Issue. 12, p. 1907.
Bipolar disorders are prevalent, often severe, and disabling illnesses with elevated lethality largely due to suicide. Suicide rates average ∼1% annually, or perhaps 60 times higher than the international population rate of 0.015% annually. Suicidal acts typically occur early in bipolar disorders and in association with severe depressive or mixed states. The high lethality of suicidal acts in bipolar disorders is suggested by a much lower ratio of attempts:suicide (∼3:1) than in the general population (∼30:1). Risk factors can help to identify patients at increased suicidal risk, but ongoing clinical assessment is essential to limit risk. Empirical short-term interventions to manage acute suicidal risk include close clinical supervision, rapid hospitalization, and electroconvulsive therapy. Remarkably, however, evidence of the long-term effectiveness of most treatments against suicidal behavior is rare. A notable exception is lithium prophylaxis, which is associated with consistent evidence of major (∼80%), sustained relative reductions of risk of suicides and attempts, and lower lethality (increased attempts:suicide ratio). Such benefits are unproved for other treatments commonly used to treat bipolar disorder patients, including anticonvulsants, antipsychotics, antidepressants, and psychosocial interventions. Applying available knowledge systematically, with close and sustained clinical supervision, can enhance management of suicidal risk in bipolar disorders patients.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.
Full text views reflects the number of PDF downloads, PDFs sent to Google Drive, Dropbox and Kindle and HTML full text views.
* Views captured on Cambridge Core between September 2016 - 27th April 2018. This data will be updated every 24 hours.